{"id":8592,"date":"2021-12-17T01:48:31","date_gmt":"2021-12-17T06:48:31","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/hot-sale-anti-cancer-peptide-lanreotide-cas-108736-35-2\/"},"modified":"2021-12-17T01:48:31","modified_gmt":"2021-12-17T06:48:31","slug":"hot-sale-anti-cancer-peptide-lanreotide-cas-108736-35-2","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/da\/product\/hot-sale-anti-cancer-peptide-lanreotide-cas-108736-35-2\/","title":{"rendered":"Hot Sale Anti Cancer Peptide Lanreotide CAS 108736-35-2"},"content":{"rendered":"

Hot Sale Anti Cancer Peptide Lanreotide CAS 108736-35-2<\/strong><\/h2>\n

Produktnavn: Lanreotide
\nSynonymer: LANREOTIDE;AUTOGEL;BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE;BIM-23014;ANGIOPEPTIN ;HD-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2;HD-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, ( DISULFIDE BOND);IPSTYL
\nCAS: 108736-35-2
\nMF: C54 H69 N11 O10 S2
\nMW: 1096.32
\nEINECS: 689-178-4
\nProduktkategorier: hormoner<& >Mol Fil: 108736-35-2.mol<\/p>\n

Lanreotid (INN) som naturlige v\u00e6ksth\u00e6mmere er lanreotid en peptidh\u00e6mmer af mange endokrine, neuroendokrine, eksokrine og parakrine funktioner. Lanreotid er mere aktivt og har en l\u00e6ngere virkningsvarighed end naturlige v\u00e6ksth\u00e6mmere. Dets h\u00e6mmende effekt p\u00e5 v\u00e6ksthormonsekretion er betydeligt mere selektiv end p\u00e5 insulinsekretion, og i 2017 godkendte FDA lanreotidacetat til injektion til behandling af neuroendokrine tumorer.<\/p>\n

Lanreotid (INN) er et l\u00e6gemiddel, der anvendes i behandling af akromegali og symptomer for\u00e5rsaget af neuroendokrine tumorer, is\u00e6r carcinoid syndrom.<\/p>\n

Lanreotid bruges til behandling af akromegali p\u00e5 grund af b\u00e5de hypofyse- og ikke-hypofyse-v\u00e6ksthormon-udskillende tumorer, og h\u00e5ndtering af for\u00e5rsagede symptomer af neuroendokrine tumorer, is\u00e6r carcinoide tumorer og VIPomas. I USA og Canada er lanreotid kun indiceret til behandling af akromegali. I Det Forenede Kongerige er det ogs\u00e5 indiceret til behandling af thyrotrofisk adenom, en sj\u00e6lden tumor i hypofysen, som udskiller TSH.<\/p>\n

Lanreotid viser ogs\u00e5 aktivitet mod ikke-endokrine tumorer, og sammen med andre somatostatinanaloger , bliver unders\u00f8gt som et muligt generelt antitumormiddel.<\/p>\n

Lanreotid CAS 108736-35-2 Kemiske egenskaber<\/strong>
\nKogepunkt 1508,2\u00b165,0 \u00b0C(Forudsagt)
\ndensitet 1,40\u00b10,1 g\/cm3( Forudsagt)
\nopbevaringstemp. Opbevares p\u00e5 et m\u00f8rkt sted, Forseglet t\u00f8rt, Opbevares i fryseren, under -20\u00b0C
\npka 9,90\u00b10,15(forudsagt)<\/p>\n

Funktion og anvendelse af Lanreotid CAS 108736-35-2<\/strong>
\nLanreotid er anvendes til behandling af akromegali, p\u00e5 grund af b\u00e5de hypofyse- og ikke-hypofyse-v\u00e6ksthormon-udskillende tumorer, og h\u00e5ndtering af symptomer for\u00e5rsaget af neuroendokrine tumorer, is\u00e6r carcinoide tumorer og VIPomas. I USA og Canada er lanreotid kun indiceret til behandling af akromegali. I Storbritannien er det ogs\u00e5 indiceret til behandling af thyrotrofisk adenom, en sj\u00e6lden tumor i hypofysen, som udskiller.<\/p>\n

Lanreotid viser ogs\u00e5 aktivitet mod ikke-endokrine tumorer, og sammen med andre somatostatinanaloger, er ved at blive unders\u00f8gt som et muligt generelt antitumormiddel.<\/p>\n

Lanreotid ,I december 2014 godkendte det amerikanske FDA lanreotid til behandling af patienter med uoperable, godt eller moderat differentierede, lokalt fremskredne eller metastatiske gastroenteropancreatiske neuroendokrine tumorer (GEP-NETs) ).<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktnavn: Lanreotid
\nCAS: 108736-35-2
\nMF: C54 H69 N11 O10 S2
\nMW: 1096.32
\nEINECS: 689-178-4
\nProduktkategorier: hormoner
\n Mol Fil: 108736-35-2.mol<\/p>\n","protected":false},"featured_media":2098,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[391],"product_tag":[],"class_list":{"0":"post-8592","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-tumor-peptid","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product\/8592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/comments?post=8592"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media\/2098"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media?parent=8592"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_brand?post=8592"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_cat?post=8592"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_tag?post=8592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}